
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company. The company focused on the development and commercialization of cell therapies as novel cancer immunotherapy products designed to harness the power of a patient's immune system to eradicate cancer cells. Its lead pipeline can... Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company. The company focused on the development and commercialization of cell therapies as novel cancer immunotherapy products designed to harness the power of a patient's immune system to eradicate cancer cells. Its lead pipeline candidate, LN-145, is an adoptive cell therapy using tumor-infiltrating lymphocytes to treat patients with refractory metastatic melanoma. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.01 | -0.581395348837 | 1.72 | 1.82 | 1.67 | 6992471 | 1.7388657 | CS |
4 | -0.47 | -21.5596330275 | 2.18 | 2.47 | 1.66 | 11464304 | 2.01287751 | CS |
12 | -1.66 | -49.2581602374 | 3.37 | 3.73 | 1.6385 | 13598917 | 2.20051796 | CS |
26 | -5.77 | -77.1390374332 | 7.48 | 7.69 | 1.6385 | 11613186 | 3.31668571 | CS |
52 | -5.64 | -76.7346938776 | 7.35 | 12.505 | 1.6385 | 8934464 | 5.5233651 | CS |
156 | -10.34 | -85.8091286307 | 12.05 | 18.33 | 1.6385 | 6738849 | 7.28940423 | CS |
260 | -27.45 | -94.1358024691 | 29.16 | 54.2081 | 1.6385 | 4934710 | 9.98712313 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions